Diabetes, smartphones, and robots: how an ‘artificial pancreas’ might help people with type 2 diabetes and kidney failure 29 September 2021 Managing blood glucose levels in people living with type 2 diabetes and kidney failure has historically been challenging. Good news, from an unlikely source, may be on the horizon. A recent trial of an artificial pancreas has reported very positive results. The technology, usually associated with managing type 1 diabetes, involves an external device that is made up of three components: a glucose sensor, a computer algorithm used to calculate insulin dosages, and an insulin pump. This is then connected to your smartphone. The software on your smartphone sends signals to the insulin pump to adjust the dosage as required. The study, undertaken by the University of Cambridge and the University Hospital of Bern, Switzerland, shows that the use of an artificial pancreas device can safely and effectively help people with type 2 diabetes and kidney failure manage their blood glucose levels. The study found that people using the artificial pancreas spent an additional 3.5 hours a day in the target blood glucose range. The study also found that the benefits of the device improved over time, as the computer algorithm adapted to the unique needs of the wearer. An artificial pancreas should allow the wearer more freedom, as it means simpler management of blood glucose levels. At the end of the study, most users reported spending less time managing their diabetes, and less time being concerned about their blood glucose levels. Research leader Dr Charlotte Boughton from the University of Cambridge said: ‘Patients living with type 2 diabetes and kidney failure are a particularly vulnerable group and managing their condition – trying to prevent potentially dangerous highs or lows of blood sugar levels – can be a challenge. There’s a real unmet need for new approaches to help them manage their condition safely and effectively.’ Type 2 diabetes is a major cause of kidney failure, accounting for just under a third of kidney failure cases. Kidney failure increases the potential for hypoglycaemia and hyperglycaemia (extremely high or low blood glucose levels). Managing diabetes in people with both diabetes and kidney failure can be challenging. People who have experienced full kidney failure also require kidney dialysis—the regular process of removing excess water and toxins from the blood in people whose kidneys can no longer do this naturally. The device is now being developed for people with type 2 diabetes who do not require kidney dialysis. Read more here Key points: Management of blood glucose levels in people with type 2 diabetes and kidney failure can be challengingThis ‘artificial pancreas’ could be extremely useful for blood glucose management in this demographicMost users reported less day-to-day concern about their blood glucose levels when using the device
News 20 July 2026 Response to media reports from 60 Minutes, The Sydney Morning Herald, and The Age regarding regulation of diabetes technologies The safety of people living with diabetes must always come first. For many Australians, technologies such as insulin pumps and continuous glucose monitors are essential tools that help prevent dangerous high and low blood glucose levels, reduce the daily burden of living with diabetes and improve long-term health outcomes. For some individuals they can be life-changing or even life-saving. Continue Reading
Media releases 12 July 2026 Champion basketballer Lara McSpadden takes Australia’s diabetes message to the Commonwealth Games As Australian basketball star Lara McSpadden prepares to fly to Glasgow to represent Australia at the Commonwealth Games, she is... Continue Reading
Media releases 8 July 2026 Territory-led digital health innovation receives boost from national partnership A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from Diabetes Australia and Lilly Australia, in partnership with Menzies School of Health Research (Menzies). Continue Reading